← Evidence map

ArticleClinical kidney journal2025

eGFR slope modelling predicts long-term clinical benefit with nefecon in a real-world IgAN population.

Jonathan Barratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40235631